Loading…
Penumbra, Inc. is projected to rise to $437.00 by 2027, a +36% move from its current price of $320.34. PEN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $317.81 | $320.53 | $323.27 | +0.06% |
| May 30 | $316.88 | $320.72 | $324.61 | +0.12% |
| May 31 | $316.21 | $320.91 | $325.68 | +0.18% |
| Jun 1 | $315.67 | $321.10 | $326.62 | +0.24% |
| Jun 2 | $315.23 | $321.29 | $327.47 | +0.30% |
| Jun 3 | $314.84 | $321.48 | $328.27 | +0.36% |
| Jun 4 | $314.50 | $321.67 | $329.01 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $314.50 | $321.67 | $329.01 | +0.42% |
| Week 2 | $312.87 | $323.01 | $333.48 | +0.83% |
| Week 3 | $311.93 | $324.36 | $337.28 | +1.25% |
| Week 4 | $311.34 | $325.70 | $340.73 | +1.67% |
| Week 5 | $310.98 | $327.06 | $343.98 | +2.10% |
| Week 6 | $310.77 | $328.42 | $347.07 | +2.52% |
| Week 7 | $310.69 | $329.79 | $350.06 | +2.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.
It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.
In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors.
The company was incorporated in 2004 and is based in Alameda, California.
Penumbra, Inc. is a healthcare company focused on medical devices with a broad portfolio of thrombectomy and neurovascular products. The current price is $328.69 per share, and the company has a market cap of $12.93B with a market rank of 770.
The 30-day outlook features a range from $310.78 to $347.63, and the 2026 forecast provides an average price of $328.69 with a min of $300.97 and a max of $439.02, with a Neutral sentiment attached to that year.
Looking further out, the forecast shows a bullish trajectory, with the average price rising through the years to $611.49 in 2030 and continuing to higher levels, reaching $2,799.61 on average by 2050, reflecting substantial upside potential over the longer term.
A major floor 2.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 4.0% above — a clean break opens room to run.
A major ceiling 12.2% above — clearing it would confirm fresh momentum.
Key PEN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PEN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $326.50 | Sell | $325.13 | Sell |
| MA 10 | $325.35 | Sell | $325.38 | Sell |
| MA 20 | $324.71 | Sell | $325.83 | Sell |
| MA 50 | $329.05 | Sell | $328.00 | Sell |
| MA 100 | $334.24 | Sell | $324.01 | Sell |
| MA 200 | $302.67 | Buy | $308.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.32 | Neutral |
| Stoch RSI (14) | 11.20 | Buy |
| CCI (20) | -149.38 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.38 | Buy |
| ROC (12) | -0.59 | Sell |
| Bollinger %B (20,2) | 0.03 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.53 | Sell |
| Ultimate (7,14,28) | 41.70 | Neutral |
| Momentum (10) | -2.45 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 326.85 | Sell |
| ADX (14) | 17.67 | Neutral |
| ATR (14) | 1.60 | Info |
Near-term technical picture:
- Sentiment: BULLISH
- RSI(14): 60
- SMA(50): $329.53
- SMA(200): $301.83
- Support: $321.71
- Resistance: $333.00
- Thirty-day range: $310.78 to $347.63
The combination of a bullish near-term stance with a solid support level around $321.71 and a resistance near $333.00 suggests a constructive setup for the short horizon, supported by the current price proximity to the SMA50 and the 30-day range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $300.97 | $320.34 | $417.56 | 0% | Neutral | |
| $357.00 | $437.00 | $559.93 | +36% | Bullish | |
| $384.22 | $478.91 | $629.66 | +50% | Bullish | |
| $394.40 | $499.04 | $669.78 | +56% | Bullish | |
| $423.00 | $542.35 | $740.79 | +69% | Bullish | |
| $440.31 | $571.37 | $792.58 | +78% | Bullish | |
| $492.80 | $646.65 | $909.63 | +102% | Bullish | |
| $570.05 | $755.84 | $1,076.83 | +136% | Bullish | |
| $617.51 | $826.85 | $1,191.96 | +158% | Bullish | |
| $659.37 | $891.22 | $1,298.93 | +178% | Bullish | |
| $968.18 | $1,364.64 | $2,083.68 | +326% | Bullish | |
| $1,435.06 | $2,168.97 | $3,549.03 | +577% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $300.97 | $320.34 | $375.41 | +0.00% |
| June 2026 | $283.82 | $331.09 | $393.73 | +3.36% |
| July 2026 | $288.21 | $338.15 | $405.92 | +2.13% |
| August 2026 | $282.17 | $332.55 | $402.11 | -1.65% |
| September 2026 | $280.21 | $331.47 | $403.18 | -0.33% |
| October 2026 | $286.11 | $339.61 | $415.31 | +2.46% |
| November 2026 | $286.15 | $340.68 | $418.58 | +0.31% |
| December 2026 | $283.38 | $338.34 | $417.56 | -0.69% |
Click any year to see its month-by-month PEN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PEN could reach as high as $417.56, with a base case around $320.34 and support toward $300.97 — roughly 0% from $320.34. Price action looks broadly range-bound.
Expect PEN to range from $357.00 to $559.93 through 2027. The $437.00 average target implies a +36% move from current prices. That is up +36% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The PEN price prediction for 2028 points to an average of $478.91 (low $384.22, high $629.66) — a potential gain of +50% on today's $320.34. Momentum favours further upside here.
In 2029, PEN is projected to trade between $394.40 and $669.78, averaging $499.04 — a potential gain of +56% from today's $320.34. That is up +4% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Penumbra, Inc.'s 2030 outlook centres on $542.35, within a $423.00 to $740.79 range. That is up +9% on the projected 2029 average. That marks a +69% change versus current levels. Momentum favours further upside here.
By 2031, PEN could reach as high as $792.58, with a base case around $571.37 and support toward $440.31 — roughly +78% from $320.34. Buyers look set to stay in control over this stretch.
Expect PEN to range from $492.80 to $909.63 through 2032. The $646.65 average target implies a +102% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The PEN price prediction for 2033 points to an average of $755.84 (low $570.05, high $1,076.83) — a potential gain of +136% on today's $320.34. Buyers look set to stay in control over this stretch.
In 2034, PEN is projected to trade between $617.51 and $1,191.96, averaging $826.85 — a potential gain of +158% from today's $320.34. That is up +9% on the projected 2033 average. Momentum favours further upside here.
Penumbra, Inc.'s 2035 outlook centres on $891.22, within a $659.37 to $1,298.93 range. That is up +8% on the projected 2034 average. That marks a +178% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PEN could reach as high as $2,083.68, with a base case around $1,364.64 and support toward $968.18 — roughly +326% from $320.34. Momentum favours further upside here.
Expect PEN to range from $1,435.06 to $3,549.03 through 2050. The $2,168.97 average target implies a +577% move from current prices. That is up +59% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PEN today (≈ 3.121683 PEN) could be worth
$6,770.85
+$5,770.85 (+577%) by 2050 · US Dollar
Based on the average projected PEN price of $2,168.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PENwould be worth at today's price.
$1,000 invested in PEN on May 27, 2025 (≈ 3.667975 PEN) would be worth
$1,175
+$175 (+17.5%) today · 1.17× · US Dollar
Based on a PEN entry price of $272.63 vs. today's $320.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $327.38 | $978.5 | -2.2% |
| 1 month ago | $327.98 | $976.71 | -2.3% |
| 3 months ago | $341.94 | $936.83 | -6.3% |
| 6 months ago | $293.17 | $1,092.68 | +9.3% |
| 1 year ago | $272.63 | $1,175 | +17.5% |
| All time (5.0y) ago | $250.61 | $1,278.24 | +27.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PEN forecast.
Our base-case forecast reaches $640.00 around 2032.
Implied market cap at $640.00: $25.17B
Multi-year outlook:
In 2026 the average forecast price is $328.69 with a neutral sentiment, and the path from 2027 onward shows bullish sentiment with rising averages—2027 avg $469.30, 2028 avg $517.27, 2029 avg $548.57, and 2030 avg $611.49 (ROI 86). The longer horizon strengthens further, with 2031 avg $650.98 (ROI 98), 2032 avg $754.95 (ROI 129.7), 2033 avg $896.35 (ROI 172.7), 2034 avg $976.27 (ROI 197), and 2035 avg $1,064.52 (ROI 223.9).
The forecast extends to 2040 and 2050, where 2040 yields an avg of $1,686.59 (ROI 413.1) and 2050 yields an avg of $2,799.61 (ROI 751.8), both with bullish sentiment. These figures imply a strong upside trajectory over the long term, though they are estimates and subject to change in actual market conditions.
Tap a question to reveal the answer.
2030 forecast: min $476.83, avg $611.49, max $835.42; ROI 86; sentiment BULLISH.
Forecast shows neutral for 2026 and bullish from 2027 onward, with rising averages through 2030 ($611.49) and beyond (e.g., 2040 $1,686.59; 2050 $2,799.61). ROI figures rise through the years (e.g., 86 in 2030, 413.1 in 2040, 751.8 in 2050).
Yes. The 2040 maximum forecast is $2,575.58, which exceeds $2,000; the 2050 maximum forecast is $4,581.31.
The current price is $328.69.
RSI(14) 60; SMA(50) $329.53; SMA(200) $301.83; support $321.71; resistance $333.00; thirty-day range $310.78-$347.63.
Penumbra, Inc. Community Discussion
0Share your Penumbra, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.